Delivery Order SPE2DB20D3101-SPE2DB23FRES3
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,680.85, is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,114.56, is a Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML. The contract has an ultimate completion date of January 13, 2025 and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,375.24 firm-fixed-price delivery order is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a period of performance through July 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,004.96, is for the delivery of Difluprednate 0.05% eye drops in 5 milliliter vials. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.76 firm fixed-price delivery order is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a prescription medication. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. There was no set-aside designation for this award. Amerisourcebergen holds a large Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a ceiling value of $14,663.65. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, which has a maximum value of $999,999,999.00 and runs through...
- This award from the Defense Logistics Agency (DLA) is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Difluprednate 0.05% eye drops in 5 mL packaging, with a ceiling value of $2,286.72 and a performance period through February 23, 2023. This contract does not have a...
- This federal contract award, valued at $11,601.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Difluprednate 0.05% eye drops in 5 ml bottles. This contract is a delivery order and has a firm fixed price pricing type, with a completion date of May 15, 2023. The contract was awarded on May 12, 2023 and does not have a set-aside designation, indicating open competition....
- This is a $1,362.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a specialty medication, to support military healthcare programs. The delivery order has a completion date of June 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DIFLUPREDNATE 0.05% eye drops. The $1,549.50 contract has a completion date of May 2, 2023 and does not have a set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corporation is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRES3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML. The $2,877.51 firm fixed-price delivery order has a completion date of March 10, 2023 and was awarded on March 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies. This specific delivery order is not designated as a set-aside contract. The award supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical supply programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 3/9/23 |